FDA Investigator LCDR Angelica M Chica

LCDR Angelica M Chica has conducted inspections on 115 sites in 8 countries as of 02 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
115
Last Inspection Date:
02 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
100005459
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Italy, Puerto Rico, Mexico, India, Taiwan, Spain
FDA Investigators that have inspected at least one site in common with LCDR Angelica M Chica:
Aaron F Coleman, Albert A Salvador, Alexander B Anderson, Ana P Barido, Angel Catala, Ann B Borromeo, Anne E Johnson, Annette Melendez, Bailey A Uetrecht, Bill Tacket, Jr, Bonita S Chester, Brandy D Brown, Brian M Carril, Brunilda Torres, Byungja E Marciante, CDR Ileana Barreto Pettit, Chantae D Mitchell, Charlotte P Chang, Craig A Garmendia, Daniel C Skirvin, David K Glasgow, David M Wilkinson, Dianiris C Ayala, Eduardo Carbonell, Edwin J Gorney, Emily A Baldwin, Emily A Green, Eric R Holm, Ethan P Stegman, Gabriel E Muniz, Hugh M Mcclure, II, Janet B Abt, Janete F Guardia, Jennifer Lalama, Jennifer M Menendez, John J Bernal, Jonathan R Campos, Jordan M Williamson, Jose Acruz Gonzalez, Karen M Cooper, Karen M Rodriguez, Katherine V Serrano, Kathryn Suttling, Ladislav Kermet, Latrice G Jones, LCDR Randall L Morris, Leon L Crawley, Lissette Paiz, LT Richard A Lyght, Luz I Collado, Marc Balzarini, Marinee Flores Marrero, Matthew F Duff, Nicole M Bell, Omayra Nrodriguez Ruiz, Ormond, Ruth A Williams, Saundrea A Munroe, Scott B Laufenberg, Scott R Izyk, Sheri L Stephenson, Susan K Cummins, MD, MPA, Suzanne A Lovelady, Valerie L Kelesyan, Victor Spanioli, Xikui Chen (nmi), PhD

LCDR Angelica M Chica's Documents

Publish Date Document Type Title
June, 2016 EIR Angel E. Rico, MD - EIR, 2016-06-14
July, 2017 FDA 483 Esperanza Arce-Nunez - Form 483, 2017-07-05
July, 2021 EIR Ibrahim Amjad, M.D. - EIR, 2021-07-28
March, 2017 FDA 483 Joshua Yang, M.D. - Form 483, 2017-03-17
June, 2023 FDA 483 Vladimir A. Guevara Vazquez, M.D. - Form 483, 2023-06-30
March, 2022 FDA 483 Lucky Flores, M.D. - Form 483, 2022-03-03
January, 2020 FDA 483 Blanca Gonzalez, M.D. - Form 483, 2020-01-23
November, 2016 FDA 483 Phase One Solutions, Inc. - Form 483, 2016-11-25
May, 2019 FDA 483 Quotient Sciences-Miami, Inc. - Form 483, 2019-10-15
August, 2023 FDA 483 Nova Southeastern University IRB #1 - Form 483, 2023-08-17
February, 2022 FDA 483 Dario D. Altamirano, DO - Form 483, 2022-02-09
February, 2021 FDA 483 Yamil Canaan, M.D. - Form 483, 2021-02-22
September, 2020 EIR Mark A. Hernandez, M.D. - EIR, 2020-09-11
May, 2016 FDA 483 Martin Valdes, M.D. - Form 483, 2016-05-05
July, 2017 FDA 483 Andrew G. Logan, M.D. - Form 483, 2017-07-20
June, 2016 FDA 483 Angel E. Rico, MD - Form 483, 2016-06-14
September, 2021 FDA 483 Juan M. Ruiz-Unger, M.D. - Form 483, 2021-09-22
October, 2022 FDA 483 Gregory A. Guell, M.D. - Form 483, 2022-10-31
October, 2016 FDA 483 Hadi Yaziji, MD - Form 483, 2016-10-17
September, 2016 FDA 483 Weiner, Gilbert R. - Form 483, 2016-09-07
June, 2018 EIR Orlando L. Rivero, MD - EIR, 2018-06-27
August, 2021 FDA 483 Maria A. Carballosa MD - Form 483, 2021-08-26
July, 2021 FDA 483 Ibrahim Amjad, M.D. - Form 483, 2021-07-28
March, 2015 FDA 483 Steven (NMI) Zeig, MD - Form 483, 2015-03-16
February, 2023 FDA 483 Scott H. Schecter, O.D. - Form 483, 2023-02-06
September, 2023 FDA 483 Jennifer W. Leiding M.D. - Form 483, 2023-09-08
August, 2023 FDA 483 Jeanne-Elyse G. Cedeno, M.D. - Form 483, 2023-08-08
March, 2023 FDA 483 Tory Sullivan, M.D., P.A. - Form 483, 2023-03-03
April, 2018 FDA 483 Celestino P. Castellon, MD - Form 483, 2018-04-12
June, 2020 FDA 483 Evelyn Lopez-Brignoni, M.D. - Form 483, 2020-06-29
September, 2018 FDA 483 Martin Valdes, M.D. - Form 483, 2018-09-19
April, 2022 FDA 483 David F. Jativa, M.D. - Form 483, 2022-04-25
November, 2016 FDA 483 Kenia Castro, M.D. - Form 483, 2016-11-03
November, 2018 FDA 483 Jorge Acosta MD - Form 483, 2018-11-28
September, 2018 FDA 483 Dario D. Altamirano, DO - Form 483, 2018-09-21
May, 2019 EIR Quotient Sciences-Miami, Inc. - EIR, 2019-05-30
December, 2022 FDA 483 Kevin R. Bender, M.D. - Form 483, 2022-12-16
April, 2024 FDA 483 Gilberto M. Cruz, M.D. - Form 483, 2024-04-24
June, 2024 FDA 483 Peter Michael, M.D. - Form 483, 2024-06-11
February, 2024 FDA 483 Zoila M. Alen, M.D. - Form 483, 2024-02-09
July, 2024 FDA 483 Francisco J. Ricart, M.D. - Form 483, 2024-07-16
September, 2019 FDA 483 LCC Medical Research Institute, LLC - Form 483, 2019-09-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more